Literature DB >> 11422570

Guillain--Barré syndrome and Campylobacter jejuni infection.

R D Hadden1, N A Gregson.   

Abstract

Entities:  

Mesh:

Year:  2001        PMID: 11422570     DOI: 10.1046/j.1365-2672.2001.01363.x

Source DB:  PubMed          Journal:  Symp Ser Soc Appl Microbiol        ISSN: 1467-4734


× No keyword cloud information.
  5 in total

Review 1.  Dissecting the Role of Anti-ganglioside Antibodies in Guillain-Barré Syndrome: an Animal Model Approach.

Authors:  Pallavi Asthana; Joaquim Si Long Vong; Gajendra Kumar; Raymond Chuen-Chung Chang; Gang Zhang; Kazim A Sheikh; Chi Him Eddie Ma
Journal:  Mol Neurobiol       Date:  2015-09-15       Impact factor: 5.590

Review 2.  Quantifying the association between Campylobacter infection and Guillain-Barré syndrome: a systematic review.

Authors:  Kate O Poropatich; Christa L Fischer Walker; Robert E Black
Journal:  J Health Popul Nutr       Date:  2010-12       Impact factor: 2.000

3.  Declining Guillain-Barré syndrome after campylobacteriosis control, New Zealand, 1988-2010.

Authors:  Michael G Baker; Amanda Kvalsvig; Jane Zhang; Rob Lake; Ann Sears; Nick Wilson
Journal:  Emerg Infect Dis       Date:  2012-02       Impact factor: 6.883

4.  Acute paretic syndrome in juvenile White Leghorn chickens resembles late stages of acute inflammatory demyelinating polyneuropathies in humans.

Authors:  Sophie R Bader; Sonja Kothlow; Sascha Trapp; Susanne Cn Schwarz; Hans-Christian Philipp; Steffen Weigend; Ahmad R Sharifi; Rudolf Preisinger; Wolfgang Schmahl; Bernd Kaspers; Kaspar Matiasek
Journal:  J Neuroinflammation       Date:  2010-01-28       Impact factor: 8.322

Review 5.  Evidence from Human and Animal Studies: Pathological Roles of CD8(+) T Cells in Autoimmune Peripheral Neuropathies.

Authors:  Mu Yang; Corentin Peyret; Xiang Qun Shi; Nicolas Siron; Jeong Ho Jang; Sonia Wu; Sylvie Fournier; Ji Zhang
Journal:  Front Immunol       Date:  2015-10-15       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.